• About Us
    • The Venture Builder
    • Team
    • Board
  • Portfolio
    • Pipeline Companies
    • Pipeline Projects
  • Partners
  • News
  • Contact
Menu
  • About Us
    • The Venture Builder
    • Team
    • Board
  • Portfolio
    • Pipeline Companies
    • Pipeline Projects
  • Partners
  • News
  • Contact

MedXCell pipeline company CYTEA|BIO to attend the Jefferies Healthcare Conference in London (November 15-17, 2022)

Montreux, Switzerland | November 2, 2022 – CYTEA|BIO, a preclinical-stage biotechnology company focusing on allogeneic cellular immunotherapies combining non genetically modified effector cells (such as

Read More »

MedXCell SA is proud to announce the arrival of Andrew Galazka and John D. McMannis as new members of the Board and Pierre J.Magistretti as new scientific advisor

Montreux, Switzerland | March 11, 2022 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and

Read More »

MedXCell SA is pleased to announce the appointment of Dr Jean-Jacques de Dardel as a member of the Board of Directors.

Montreux, Switzerland | August 26, 2021 –  MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and accessible

Read More »

MedXCell SA has successfully closed a CHF 5.3 million Series A

Montreux, Switzerland | June 4, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and

Read More »

MedXCell SA is proud to announce the arrival of Gabriel Baertschi as a new member of the Board

Montreux, Switzerland | May 17, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and

Read More »

MedXCell SA selected to participate in the sixth edition of the pre-IPO program TechShare organized by Euronext

Montreux, Switzerland | January 21, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and

Read More »

Montreux, CH – Montpellier, FR – Cambridge MA, USA

Linkedin

This website contains information about products that may not be available in all countries, available under different trademarks or for different indications. Nothing contained herein should be considered a solicitation, promotion or advertisement for any product including those under development and described on this site. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider

© All rights reserved 2022 – MedXCell SA